...
【24h】

Two Authors Reply

机译:两位作者回复

获取原文
获取原文并翻译 | 示例

摘要

We thank Binder et al. (1) for their interest in and careful review of our article (2). First, we apologize that the column headings in Table 2 (2, p. 419) were mislabeled with “%,” but it should be clear from the table title that the incidence rates refer to events per 1,000 person-years of follow-up. Second, we did not use the Kaplan-Meier approach to draw our conclusions about cumulative incidence differences. Rather, we used the simple (and well-understood) plot in Figure 2 (2, p. 420) to illustrate the very small differences in dementia-specific survival between participants and nonparticipants. We used incidence density estimates (numbers of events per 1,000 person-years of follow-up) as our measures of dementia incidence, and we used these well-understood and -accepted epidemiologic estimates to make the primary comparisons of incidence between participant groups (3). We recognize that these estimators will produce higher estimates of incidence than will result from analyses that account for competing risks—for exactly the reasons outlined by Binder et al. (1).
机译:我们感谢Binder等。 (1)符合我们对文章(2)的兴趣和仔细审查。首先,我们很遗憾表2(2,第419页)的列标题与“%”误标配,但从表格标题中应该清楚的是,发病率是指每1000人的事件 - 多年的随访。其次,我们没有使用Kaplan-Meier方法来得出关于累积发病率差异的结论。相反,我们在图2(2,p.420)中使用了简单(和良好的)曲线图,以说明参与者和非唾液酸体之间的痴呆特异性存活率的非常小的差异。我们使用发病密度估计(每1,000人的事件数量,随访时间)作为我们对痴呆发病率的措施,我们利用这些良好的理解和接受的流行病学估计,以使参与者组之间的发病率的主要比较(3 )。我们认识到,这些估算变量会产生更高的发病率,而不是分析竞争风险的分析 - 因为Binder等人概述的原因。 (1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号